Why Dynavax Stock Is Vaulting Higher Today
Shares of Dynavax Technologies (NASDAQ: DVAX) were vaulting 7.2% higher as of 11:44 a.m. EST on Thursday. The big jump came after the biotech announced results from an ongoing clinical study evaluating hepatitis B vaccine Heplisav-B in patients undergoing hemodialysis. As you might have guessed, Dynavax had good news from the clinical trial.